Stay updated on Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision/build number was updated (v3.5.2 → v3.5.3), reflecting a site/version change rather than a change to the clinical trial record details.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the page history.SummaryDifference0.1%

- Check52 days agoChange DetectedNew revision v3.5.0 added to the Record History; revision v3.4.3 removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check88 days agoChange DetectedRevision: v3.4.2 was added to the history and the prior funding-status notice along with Revision: v3.4.1 were removed.SummaryDifference0.5%

- Check95 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and NIH operating status, and updated the revision to v3.4.1 (replacing v3.4.0).SummaryDifference0.5%

Stay in the know with updates to Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.